Location History:
- Palo Alto, CA (US) (1999)
- Tiburon, CA (US) (1998 - 2015)
- Paradise, CA (US) (2015)
Company Filing History:
4 out of 422 
2 out of 465 
1 out of 832,843 Years Active: 1998-2015
Title: Carol A. Requadt: Innovator in Enzymatic Technology
Introduction
Carol A. Requadt, an esteemed inventor based in Paradise, California, has made significant contributions to the field of enzymatic technology. With a remarkable portfolio of seven patents, her innovations have advanced the efficiency of processes related to starch liquefaction and saccharification, among other applications.
Latest Patents
Her latest patents include groundbreaking work on alpha-amylases derived from AmyE, as well as variants and nucleic acids encoding these enzymes. One key patent details methods of utilizing AmyE or its variants in liquefaction and saccharification processes, which are critical for producing sugars used in the ethanol and high fructose corn syrup industries. This innovation allows these amylases to function effectively at low pH levels and without the need for calcium or glucoamylase, significantly enhancing production efficiency. Another notable patent focuses on the α-amylase from AmyE, which can produce substantial amounts of glucose from various carbohydrate substrates, including vegetable starch, maltoheptaose, and maltotriose, further illustrating its utility in saccharification reactions.
Career Highlights
Carol's impressive career features pivotal roles in prominent companies like Genencor International, Inc. and Danisco US Inc. Her work has not only propelled her own innovations but also contributed broadly to the biotechnological landscape.
Collaborations
Throughout her career, Carol has worked alongside talented individuals such as Colin Mitchinson and Scott Douglas Power, fostering collaboration and knowledge-sharing that enhances inventive processes and approaches in enzymatic research.
Conclusion
Carol A. Requadt’s innovative spirit and her dedication to advancing enzymatic technology firmly position her as a leader in her field. Her patents serve as a testament to her commitment to improving industrial processes and increasing the efficiency of biotechnological applications. As she continues her work, her impact on the industry is sure to be felt for years to come.